Achievement of Complete Response and Drug-Free Status by Atezolizumab plus Bevacizumab Combined with or without Curative Conversion in Patients with Transarterial Chemoembolization-Unsuitable, Intermediate-Stage Hepatocellular Carcinoma: A Multicenter Proof-Of-Concept Study

Masatoshi Kudo, Tomoko Aoki, Kazuomi Ueshima, +19

Liver Cancer

Complications after Radiofrequency Ablation for Hepatocellular Carcinoma: A Multicenter Study Involving 9,411 Japanese Patients

Masaki Maeda, Issei Saeki, Isao Sakaida, +28

Liver Cancer

MRP3 as a novel resistance factor for sorafenib in hepatocellular carcinoma

Tetsu Tomonari, Shunsaku Takeishi, Tatsuya Taniguchi, +8

Oncotarget

Serum diamine oxidase activity as a predictor of gastrointestinal toxicity and malnutrition due to anticancer drugs

Jinsei Miyoshi, Hiroshi Miyamoto, Takahiro Goji, +10

Journal of Gastroenterology and Hepatology

Conversion therapy for unresectable hepatocellular carcinoma after lenvatinib

Tetsu Tomonari, Yasushi Sato, Hironori Tanaka, +11

Medicine

MiR-125b-5p Is Involved in Sorafenib Resistance through Ataxin-1-Mediated Epithelial-Mesenchymal Transition in Hepatocellular Carcinoma

Akihiro Hirao, Yasushi Sato, Hironori Tanaka, +14

Cancers

Parental Cell LinesTumor BiologyPlc/prf5 CellsOncologyMedicine +12

Clinical Features and Outcomes of Conversion Therapy in Patients with Unresectable Hepatocellular Carcinoma

Tetsu Tomonari, Joji Tani, Yasushi Sato, +10

Cancers

Comparison of therapeutic outcomes of sorafenib and lenvatinib as primary treatments for hepatocellular carcinoma with a focus on molecular‐targeted agent sequential therapy: A propensity score‐matched analysis

Tetsu Tomonari, Yasushi Sato, Joji Tani, +13

Hepatology Research

Potential use of lenvatinib for patients with unresectable hepatocellular carcinoma including after treatment with sorafenib: Real-world evidence and <i>in vitro</i> assessment via protein phosphorylation array

Tetsu Tomonari, Yasushi Sato, Hironori Tanaka, +14

Oncotarget

Novel des‐γ‐carboxy prothrombin in serum for the diagnosis of hepatocellular carcinoma

Takahiro Tanaka, Tatsuya Taniguchi, Katsutaka Sannomiya, +9

Journal of Gastroenterology and Hepatology